MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR B- ALL
137 Ratings
Rs 13,624 Rs 10,400
24 % OFF
DETECTION OF MINIMAL RESIDUAL DISEASE (MRD) IN ACUTE LYMPHOBLASTIC LEUKEMIA PREDICTS OUTCOME. THIS ASSAY CAN IDENTIFY PATIENTS AT HIGHER/LOWER RISK OF RELAPSE. DETECTION OF MRD IS IMPORTANT FOR RISK ASSESSMENT AND STRATIFICATION OF THERAPY.
Why book with us?
-
Free and On Schedule Sample Collection
-
24/7 Service
-
Affordable
-
Quick and Accurate Reports
3 ML (1 ML MIN.) FIRST PULL BONE MARROW ASPIRATE IN 1 GREEN TOP (SODIUM HEPARIN) TUBE. SHIP IMMEDIATELY AT 18-22 C. DO NOT FREEZE. IT IS MANDATORY TO PROVIDE DATE & TIME OF SAMPLING, PREVIOUS IMMUNOPHENOTYPE REPORT & CLINICAL HISTORY.
FLOW CYTOMETRY
REPORT ON 4TH DAY EVENING 7PM
IT IS MANDATORY TO PROVIDE DATE & TIME OF SAMPLING, PREVIOUS IMMUNOPHENOTYPE REPORT & CLINICAL HISTORY.
